In a filing, Biolife Solutions Inc revealed its 10% Owner Casdin Partners Master Fund, L unloaded Company’s shares for reported $23.8 million on Jun 10 ’25. In the deal valued at $23.80 per share,1,000,000 shares were sold. As a result of this transaction, Casdin Partners Master Fund, L now holds 7,707,165 shares worth roughly $169.79 million.
Then, Berard Todd sold 362 shares, generating $8,579 in total proceeds. Upon selling the shares at $23.70, the Chief Marketing Officer now owns 134,922 shares.
Before that, Mathew Aby J. sold 637 shares. Biolife Solutions Inc shares valued at $15,097 were divested by the EVP & Chief Scientific Officer at a price of $23.70 per share. As a result of the transaction, Mathew Aby J. now holds 353,118 shares, worth roughly $7.78 million.
H.C. Wainwright initiated its Biolife Solutions Inc [BLFS] rating to a Buy in a research note published on September 30, 2024; the price target was $29. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Craig Hallum began covering BLFS with “Buy” recommendation on July 11, 2023. Oppenheimer revised its rating on April 25, 2022. It rated BLFS as “an Outperform” which previously was an “a Perform”.
Price Performance Review of BLFS
On Friday, Biolife Solutions Inc [NASDAQ:BLFS] saw its stock fall -5.45% to $22.03. Over the last five days, the stock has lost -7.09%. Biolife Solutions Inc shares have fallen nearly -15.14% since the year began. Nevertheless, the stocks have risen 2.90% over the past one year. While a 52-week high of $29.55 was reached on 01/30/25, a 52-week low of $18.70 was recorded on 04/09/25.
Levels Of Support And Resistance For BLFS Stock
The 24-hour chart illustrates a support level at 21.51, which if violated will result in even more drops to 20.99. On the upside, there is a resistance level at 22.80. A further resistance level may holdings at 23.56.
How much short interest is there in Biolife Solutions Inc?
A steep rise in short interest was recorded in Biolife Solutions Inc stocks on 2025-05-30, growing by 0.74 million shares to a total of 4.68 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 3.94 million shares. There was a rise of 15.81%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 19, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $61 price target.
